New computer programme could help assess cancer risks

(Computer support for recording and interpreting family histories of breast and ovarian cancer in primary care (RAGs): qualitative evaluation with simulated patients)

A new computer programme, to help family doctors work with patients to assess their genetic risk of cancer, seems to have faired well in initial trials, the results of which are published in this week's BMJ. A collaboration between the Cancer Research Campaign and the Imperial Cancer Research Fund, risk assessment in genetics' (RAGs) is a computer programme which draws pedigrees, assesses risk based on a family history of breast and ovarian cancer and suggests an appropriate course of action.

The study was conducted with 15 general practitioners, each consulted by two female patients, played by actors, concerned about their risk of cancer. Most of the doctors involved in the study found the programme easy to use and that it enabled them to tackle the complex area of assessing genetic risk with their patients. However, users also reported a sense of being out of control' during the consultation. For example, some participants found it awkward sitting next to their patient, with the screen in front of them, unable to predict the information that would be displayed. When the programme calculated that a patient should be considered high risk' doctors commented that they felt a sense of panic and wanted to turn the screen away from the patient in order to break the bad news more gently.

The authors of the study also found that some users were uncomfortable with the speed of the programme. Some preferred to stage' the process of assessment so that they had time to prepare themselves for presenting bad news to a patient. Some users found it difficult to access the additional information explaining what the risk assessment actually meant for the patient, which was contained within the programme. Once they found these explanations they were able to reassure the patient and

Contact: Jill Shepherd
BMJ-British Medical Journal

Page: 1 2

Related biology news :

1. Computer scientists at UH developing nurturing computers
2. NIST study shows computerized fingerprint matching is highly accurate
3. Emory scientists receive NIH MIDAS grant for computer modeling of infectious diseases
4. Biological computer diagnoses cancer and produces drug in a test tube
5. Frog skin and supercomputers lead Penn chemists to designing better bacteria killers
6. UN study shows environmental consequences from ongoing boom in personal computer sales
7. Researchers develop computer application to read medical literature, find data relationships
8. Human migration tracked in Stanford computer simulation
9. St. Jude ranked among top 500 supercomputer centers
10. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
11. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans

Post Your Comments:

(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... pleased to announce the next event in a series of TOPIQ webinars, which ... TOPIQ series of webinars was developed in response to social distancing measures that ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Institute of Technology (MIT) has expanded the company’s exclusive license to include ... into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. ...
(Date:7/10/2020)... , ... July 09, 2020 , ... ... cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as ... oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson serves ...
Breaking Biology Technology:
Cached News: